Insulin aspart, recombinant Subcutaneous and Solifenacin Tablets
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Solifenacin Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: solifenacin
Brand name: VESIcare
Synonyms: Solifenacin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Soliqua
- Insulin aspart, recombinant Subcutaneous-Soliqua 100/33
- Insulin aspart, recombinant Subcutaneous-Soliris
- Insulin aspart, recombinant Subcutaneous-Solmara Patch
- Insulin aspart, recombinant Subcutaneous-Solodyn
- Insulin aspart, recombinant Subcutaneous-Solosec
- Solifenacin Tablets-Insulin degludec
- Solifenacin Tablets-Insulin Degludec (U-100) Prefilled Pens
- Solifenacin Tablets-Insulin Degludec (U-100) Vials
- Solifenacin Tablets-Insulin Degludec (U-200) Prefilled Pens
- Solifenacin Tablets-Insulin degludec and liraglutide
- Solifenacin Tablets-Insulin degludec and liraglutide Subcutaneous